Hyperion Therapeutics Inc (HPTX.OQ)

HPTX.OQ on NASDAQ Stock Exchange Global Select Market

24.97USD
16 Apr 2014
Price Change (% chg)

$0.37 (+1.50%)
Prev Close
$24.60
Open
$24.43
Day's High
$25.36
Day's Low
$24.21
Volume
21,816
Avg. Vol
26,765
52-wk High
$32.98
52-wk Low
$17.41

HPTX.OQ

Chart for HPTX.OQ

About

Hyperion Therapeutics, Inc. (Hyperion)is a development-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology. The Company develops Ravicti (glycerol phenylbutyrate) to treat the prevalent urea cycle disorders (UCD)... (more)

Overall

Beta: --
Market Cap (Mil.): $496.42
Shares Outstanding (Mil.): 20.18
Dividend: --
Yield (%): --

Financials

  HPTX.OQ Industry Sector
P/E (TTM): 36.08 32.56 32.65
EPS (TTM): 0.68 -- --
ROI: 20.21 19.75 19.01
ROE: 21.58 20.45 19.78
Search Stocks

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $98.75 -0.45
Pfizer Inc. (PFE.N) $30.09 +0.20
Novartis AG (NOVN.VX) CHF74.35 +0.80
Merck & Co., Inc. (MRK.N) $56.26 +0.21
Roche Holding Ltd. (ROG.VX) CHF254.20 +0.90
Abbott Laboratories (ABT.N) $38.38 +0.41
Bayer AG (BAYGn.DE) €92.93 +1.42
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €74.77 +0.75

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks